Vaccines companies

  • Report ID: 1399
  • Published Date: Jun 19, 2025
  • Report Format: PDF, PPT

Key Vaccines Market Players:

    The competitive landscape of the vaccines market is rapidly evolving as established key players, healthcare giants, and new entrants are investing in including novel medicines. Key players in the market are focused on developing new technologies and products that cater to the stringent regulatory norms and consumer demand.  These key players are adopting several strategies, such as mergers and acquisitions, joint ventures, partnerships, and novel product launches, to enhance their product base and strengthen their market position.

    Top 15 Global Manufacturers in Vaccines Market

    Company Name

    Country

    Est. Market Share (2024)

    Pfizer Inc.

    USA

    12.6%

    GlaxoSmithKline plc (GSK)

    UK

    10.9%

    Moderna, Inc.

    USA

    9.8%

    Sanofi Pasteur

    France

    9.3%

    Serum Institute of India Pvt. Ltd.

    India

    8.1%

    Johnson & Johnson (Janssen)

    USA

    xx%

    CSL Seqirus

    Australia

    xx%

    Novavax, Inc.

    USA

    xx%

    Daiichi Sankyo Co., Ltd.

    Japan

    xx%

    Bharat Biotech

    India

    xx%

    Zydus Lifesciences

    India

    xx%

    SK Bioscience Co., Ltd.

    South Korea

    xx%

    BioNTech SE

    Germany

    xx%

    Chiron Panacea Biotec

    India

    xx%

    Medigen Vaccine Biologics

    Taiwan

    xx%

    Below are the areas covered for each company in the global vaccines market

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of vaccines is evaluated at USD 85 billion.

Vaccines Market size was valued at USD 82.96 Billion in 2024 and is projected to cross USD 174.79 Billion by the end of 2037, expanding at more than 5.9% CAGR during the forecast period i.e., between 2025-2037.

The North America vaccines market is anticipated to dominate, garnering a 38.6% share globally.

Pfizer Inc., GlaxoSmithKline plc (GSK), Moderna, Inc., Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Johnson & Johnson (Janssen), CSL Seqirus, Novavax, Inc., Daiichi Sankyo Co. Ltd., Bharat Biotech, Zydus Lifesciences, SK Bioscience Co. Ltd., BioNTech SE, Chiron Panacea Biotec, Medigen Vaccine Biologics.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos